RBC Capital Maintains Outperform on Zynex, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has maintained an Outperform rating on Zynex (NASDAQ:ZYXI) and increased the price target from $13 to $15.
March 01, 2024 | 3:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has reaffirmed its Outperform rating on Zynex and raised the price target from $13 to $15.
The upgrade in price target by a reputable analyst like Shagun Singh from RBC Capital is a strong positive signal for Zynex. It suggests confidence in the company's future performance and growth prospects, likely leading to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100